Titin isoform switch in ischemic human heart disease
- PMID: 12221049
- DOI: 10.1161/01.cir.0000029803.93022.93
Titin isoform switch in ischemic human heart disease
Abstract
Background: Ischemia-induced cardiomyopathy usually is accompanied by elevated left ventricular end-diastolic pressure, which follows from increased myocardial stiffness resulting from upregulated collagen expression. In addition to collagen, a main determinant of stiffness is titin, whose role in ischemia-induced left ventricular stiffening was studied here. Human heart sarcomeres coexpress 2 principal titin isoforms, a more compliant N2BA isoform and a stiffer N2B isoform. In comparison, normal rat hearts express almost no N2BA titin.
Methods and results: Gel electrophoresis and immunoblotting were used to determine the N2BA-to-N2B titin isoform ratio in nonischemic human hearts and nonnecrotic left ventricle of coronary artery disease (CAD) patients. The average N2BA-to-N2B ratio was 47:53 in severely diseased CAD transplanted hearts and 32:68 in nonischemic transplants. In normal donor hearts and donor hearts with CAD background, relative N2BA titin content was approximately 30%. The titin isoform shift in CAD transplant hearts coincided with a high degree of modifications of cardiac troponin I, probably indicating increased preload. Immunofluorescence microscopy on CAD transplant specimens showed a regular cross-striated arrangement of titin and increased expression of collagen and desmin. Force measurements on isolated myofibrils revealed reduced passive-tension levels in sarcomeres of CAD hearts with high left ventricular end-diastolic pressure compared with sarcomeres of normal hearts. In a rat model of ischemia-induced myocardial infarction (left anterior descending coronary artery ligature), 43% of animals, but only 14% of sham-operated animals, showed a distinct N2BA titin band on gels.
Conclusions: A titin isoform switch was observed in chronically ischemic human hearts showing extensive remodeling, which necessitated cardiac transplantation. The shift, also confirmed in rat hearts, caused reduced titin-derived myofibrillar stiffness. Titin modifications in long-term ischemic myocardium could impair the ability of the heart to use the Frank-Starling mechanism.
Comment in
-
Giant molecule titin and myocardial stiffness.Circulation. 2002 Sep 10;106(11):1302-4. doi: 10.1161/01.cir.0000031760.65615.3b. Circulation. 2002. PMID: 12221041 No abstract available.
-
Titin stiffness in heart disease.Circulation. 2003 Mar 25;107(11):e73; author reply e73. doi: 10.1161/01.cir.0000060810.93701.22. Circulation. 2003. PMID: 12654620 No abstract available.
-
Variable titin-based stiffness adjustment in heart disease.Circulation. 2003 Jul 29;108(4):e23. doi: 10.1161/01.CIR.0000081439.94575.E3. Circulation. 2003. PMID: 12885736 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous